Jupiter Asset Management Ltd. Takes $37.77 Million Position in Humana Inc. $HUM

Jupiter Asset Management Ltd. bought a new stake in Humana Inc. (NYSE:HUM) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 147,477 shares of the insurance provider’s stock, valued at approximately $37,773,000. Jupiter Asset Management Ltd. owned 0.12% of Humana as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also modified their holdings of HUM. Montag A & Associates Inc. boosted its holdings in Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 94 shares during the period. CoreCap Advisors LLC grew its stake in Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after buying an additional 37 shares in the last quarter. Rosenberg Matthew Hamilton grew its stake in Humana by 136.0% during the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after buying an additional 68 shares in the last quarter. Larson Financial Group LLC grew its stake in Humana by 114.1% during the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock worth $40,000 after buying an additional 81 shares in the last quarter. Finally, Fulcrum Asset Management LLP acquired a new stake in Humana during the third quarter worth about $42,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Stock Up 0.7%

Shares of NYSE HUM opened at $308.41 on Friday. The company has a 50 day simple moving average of $229.25 and a 200 day simple moving average of $228.50. The firm has a market cap of $37.03 billion, a PE ratio of 32.99, a price-to-earnings-growth ratio of 2.22 and a beta of 0.68. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $315.66. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The business had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The firm’s quarterly revenue was up 23.5% on a year-over-year basis. During the same quarter last year, the business earned $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. On average, research analysts forecast that Humana Inc. will post 9.01 EPS for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 annualized dividend and a yield of 1.1%. Humana’s dividend payout ratio (DPR) is presently 37.86%.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on HUM. Needham & Company LLC began coverage on shares of Humana in a research note on Wednesday, May 20th. They set a “buy” rating on the stock. Royal Bank Of Canada raised their price target on shares of Humana from $189.00 to $246.00 and gave the company a “sector perform” rating in a research note on Thursday, April 30th. Jefferies Financial Group upgraded shares of Humana from a “buy” rating to a “buy” rating in a research note on Wednesday, May 20th. Piper Sandler restated a “neutral” rating and issued a $254.00 price target (up from $182.00) on shares of Humana in a research note on Wednesday, May 13th. Finally, Evercore raised their price target on shares of Humana from $195.00 to $250.00 in a research note on Thursday, April 30th. Nine equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $270.48.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.